| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Co-Chief Executive Officer | Common Stock | 423K | $322K | $1.77 | Mar 11, 2024 | Direct |
| Imunon, Inc. | President and CEO, Director | Imunon Common Stock | 264K | $259K | $0.98 | Aug 15, 2024 | Direct |
| Imunon, Inc. | President and CEO, Director | Stock Option (Right to Buy) | 303K | Sep 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IMNN | Imunon, Inc. | Sep 10, 2024 | 1 | $0 | 4 | Sep 10, 2024 | President and CEO, Director |
| IMNN | Imunon, Inc. | Aug 16, 2024 | 1 | $24.5K | 4 | Aug 16, 2024 | President and CEO, Director |
| IMNN | Imunon, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | President and CEO, Director |
| IMNN | Imunon, Inc. | May 13, 2024 | 1 | $0 | 4 | May 14, 2024 | President and CEO, Director |
| IMNN | Imunon, Inc. | Mar 15, 2024 | 1 | $0 | 4 | Mar 18, 2024 | Director |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Mar 11, 2024 | 1 | $0 | 4 | Mar 13, 2024 | Co-Chief Executive Officer |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Sep 1, 2023 | 1 | $20.4K | 4 | Sep 5, 2023 | Co-Chief Executive Officer |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Aug 2, 2023 | 1 | $0 | 4 | Aug 7, 2023 | Co-Chief Executive Officer |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Apr 20, 2023 | 1 | $0 | 4 | Apr 24, 2023 | Co-Chief Executive Officer |
| IMNN | Imunon, Inc. | Mar 17, 2023 | 1 | $0 | 4 | Mar 21, 2023 | Director |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Dec 7, 2022 | 1 | $0 | 4 | Jan 4, 2023 | Co-Chief Executive Officer |
| IMNN | Celsion CORP | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
| IMNN | Celsion CORP | Mar 4, 2022 | 1 | $0 | 4 | Mar 7, 2022 | Director |
| IMNN | Celsion CORP | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |
| IMNN | Celsion CORP | Jun 4, 2021 | 0 | $0 | 3 | Jun 8, 2021 | Director |